Bev Ingram, PhD Pfizer Inc.

Dr. Bev Ingram is a Senior Director within the Global Regulatory Affairs team supporting the biosimilar products portfolio at Pfizer Inc. She is located at the Manufacturing and Pharmaceutical Science R&D facility in Massachusetts USA where she has a global portfolio development role and global regulatory lead. Bev has been working in the area of biosimilars since 2010 and has engaged with regulatory agencies including FDA, EMA and PMDA regarding a range of biosimilar development topics. She is a highly experienced Regulatory professional with over 20 years industry experience, managing full product life-cycle for small and large molecules and preparing global regulatory submissions including biosimilars, monoclonal antibodies and antibody drug conjugates. She has previously worked for GlaxoSmithKline and Wyeth. She started her scientific career in the pharmaceutical industry supporting development of cell culture processes for the production of therapeutic macromolecules by mammalian and microbial cells, having gained her PhD at the University of Manchester Institute of Science & Technology (UK).